Clinical Trials in Seattle

Showing 7901-7920 of 9,312 trials

A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

NCT00515697

The purpose of this study is to determine whether ramucirumab is effective treatment in participants with metastatic renal cell carcinoma who have developed progressive disease or become intolerant to tyrosine kinase inhibitor therapy.

Metastatic Renal Cell Carcinoma

Eli Lilly and Company39 participantsStarted Nov 2007

San Francisco, California, United States • Chicago, Illinois, United States • Metairie, Louisiana, United States +8 more locations

TERMINATEDPhase 3< 1 mile

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

NCT00441558

To determine if long-term treatment with Flibanserin is safe and to monitor the effectiveness of Flibanserin in Women with HSDD that have already completed a previous study (511.70/71/.74/.75/.105) with Flibanserin.

Sexual Dysfunctions, Psychological

Sprout Pharmaceuticals, Inc1,723 participantsStarted Feb 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +193 more locations

A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

Find Trials by Condition in Seattle

Ultrasound-guided Rectus Sheath Block for Post-operative Pain Control Following Umbilical Hernia Repair

Pramipexole ER vs. Placebo in Fibromyalgia

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis

Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

A Trial of Degarelix in Patients With Prostate Cancer

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

Patient Registry Study of Berinert® in Normal Clinical Practice

12 / 48 Week Pivotal PFT vs PBO in COPD I

Dapagliflozin DPPIV Inhibitor add-on Study

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

Growth and Tolerance of Infants Fed Infant Formulas

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome